Cargando…
Evaluation of the Pharmacokinetics of the Pancreastatin Inhibitor PSTi8 Peptide in Rats: Integration of In Vitro and In Vivo Findings
PSTi8 is a pancreastatin inhibitory peptide that is effective in the treatment of diabetic models. This study investigates the pharmacokinetic (PK) properties of PSTi8 in Sprague Dawley rats, for the first time. In vitro and in vivo PK studies were performed to evaluate the solubility, stability in...
Autores principales: | Valicherla, Guru R., Katekar, Roshan A., Dadge, Shailesh, Riyazuddin, Mohammed, Syed, Anees A., Singh, Sandeep K., Husain, Athar, Wahajuddin, Muhammad, Gayen, Jiaur R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780964/ https://www.ncbi.nlm.nih.gov/pubmed/35056659 http://dx.doi.org/10.3390/molecules27020339 |
Ejemplares similares
-
Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus
por: Hossain, Zakir, et al.
Publicado: (2018) -
Combination of Pancreastatin inhibitor PSTi8 with metformin inhibits Fetuin-A in type 2 diabetic mice
por: Singh, Pragati, et al.
Publicado: (2020) -
Simultaneous Estimation of Quercetin and trans-Resveratrol in Cissus quadrangularis Extract in Rat Serum Using Validated LC-MS/MS Method: Application to Pharmacokinetic and Stability Studies
por: Dadge, Shailesh D., et al.
Publicado: (2023) -
PSTi8 with metformin ameliorates perimenopause induced steatohepatitis associated ER stress by regulating SIRT-1/SREBP-1c axis
por: Singh, Pragati, et al.
Publicado: (2020) -
Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity
por: Valicherla, Guru R., et al.
Publicado: (2016)